Astonea Labs Board Approves Subsidiary, Auditor Appointment, and Agreement Termination

Astonea Labs Ltd. held a board meeting on September 9, 2026, where several key decisions were made. The board took on record the Cost Audit Report for FY 2025-26, noting no adverse remarks. They approved the appointment of Mr. Chander Shekhar as the Internal Auditor for FY 2026-27. A significant decision was the approval for the incorporation of a new subsidiary, 'LONGEVITY SCIENCE PRIVATE LIMITED', in which Astonea Labs will hold at least 51% voting power. The company also approved an initial capital investment of up to USD 10,000 in its US wholly-owned subsidiary, Astonea LLC. Finally, the board confirmed the immediate termination of agreements with Astonea One Private Limited, superseding a previous deferral.